[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Orthopedics Market Consolidation 2017-2022: Who will not survive?

January 2018 | 136 pages | ID: C4FD06CE3C3EN
Venture Planning Group

US$ 4,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Will the $50 billion global orthopedics industry consolidate, decentralize, or undergo a bimodal transformation?

How will the current trends affect the major market segments?

Which companies will enter the market and which will not survive?
I. MARKET OVERVIEW

    a. U.S.A
  1. Business Environment
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Industry Consolidation
    d. Managed Care
    e. Hospitals
    f. Admissions
    g. Length of Stay
    h. Industry Diversification
    i. Physician Demographics
    j. Population Aging
    b. Other Countries

II. MARKET SIZE AND GROWTH

    a. Major Market Segments
    b. Major Geographic Regions

III. EMERGING TECHNOLOGIES

    a. Overview
    b. Resorbables
    c. Bone Substitutes
    d. Osteoinductive Agents/
Bone Graft Factors
    e. Soft Tissue Repair And Replacement
    f. Viscoelastics
    g. Osteoporosis Therapies

IV. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS

Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses

V. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS

The U.S. and international sales force size
Distribution approaches
Major promotional tactics

VI. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL KNOW-HOW INTERNALLY DEVELOPED AND ACQUIRED TECHNOLOGIES

Technical expertise in biotechnology, engineering and other pertinent fields


More Publications